-
[YEAR:5-8-2005]Arasappan,A., Njoroge,F.G., Chan,T.Y., Bennett,F., Bogen,S.L., Chen,K., Gu,H., Hong,L., Jao,E., Liu,Y.T., Lovey,R.G., Parekh,T., Pike,R.E., Pinto,P., Santhanam,B., Venkatraman,S., Vaccaro,H., Wang,H., Yang,X., Zhu,Z., McKittrick,B., Saksena,A.K., Girijavallabhan,V., Pichardo,J., Butkiewicz,N., Ingram,R., Malcolm,B., Prongay,A., Yao,N., Marten,B., Madison,V., Kemp,S., Levy,O., Lim-Wilby,M., Tamura,S. and Ganguly,A.K.
Hepatitis C virus NS3-4A serine protease inhibitors: SAR of P2' moiety with improved potency
Bioorg Med Chem Lett15, 4180-4184. PubMed Europe PubMed DOI I
2005
